Aclaris Therapeutics Inc Asset Turnover Ratio (ACRS), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aclaris Therapeutics Inc   (NASDAQ: ACRS)
 

Aclaris Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aclaris Therapeutics Inc asset turnover ratio, the ability of Aclaris Therapeutics Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.05 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as ACRS's position remain challenging.

Within sector 134 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2423, from total ranking in the fourth quarter 2025 at 3071.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACRS Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -0.61 % -27.48 % -3.54 % 16.87 % 14.21 %
Y / Y Revenue Change 37.18 % -85.94 % -24.09 % -35.76 % -39.32 %
Asset Turnover Ratio (TTM) 0.05 0.04 0.08 0.08 0.09
ACRS's Total Ranking # 2423 # 3071 # 121 # 2781 # 229
Seq. Asset Change 23.84 % -9.19 % -7.08 % -4.9 % -9.63 %
Seq. Revenue Change 54.13 % -60.75 % 85.65 % 22.13 % -84.2 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 135
Healthcare Sector # 380
Overall Market # 2423

Asset Turnover Ratio Statistics
High Average Low
0.17 0.07 -0.03
(Jun 30 2024)   (Sep 30 2020)




ACRS Company Profile • Back to ACRS Efficiency Comparisons • Compare ACRS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Arvinas Inc   0.11 $ 89.400  Millions$ 779.750  Millions
C4 Therapeutics Inc   0.11 $ 34.861  Millions$ 312.488  Millions
Sintx Technologies Inc   0.11 $ 1.029  Millions$ 9.469  Millions
Protagonist Therapeutics inc   0.11 $ 74.063  Millions$ 696.335  Millions
Bolt Biotherapeutics Inc   0.11 $ 6.499  Millions$ 61.332  Millions
Kura Oncology Inc   0.11 $ 71.639  Millions$ 680.680  Millions
Lipocine Inc   0.10 $ 2.002  Millions$ 19.254  Millions
Vystar Corporation  0.10 $ 0.048  Millions$ 0.470  Millions
Viridian Therapeutics Inc   0.10 $ 70.904  Millions$ 731.639  Millions
Omniab Inc   0.10 $ 28.939  Millions$ 299.982  Millions
Metagenomi Therapeutics Inc   0.10 $ 22.331  Millions$ 234.569  Millions
Abeona Therapeutics Inc   0.09 $ 20.140  Millions$ 223.848  Millions
Therapeuticsmd Inc   0.09 $ 3.353  Millions$ 38.103  Millions
Ocular Therapeutix Inc   0.09 $ 52.038  Millions$ 600.700  Millions
Monte Rosa Therapeutics Inc   0.09 $ 42.953  Millions$ 501.129  Millions
Bicycle Therapeutics Plc  0.09 $ 63.496  Millions$ 741.533  Millions
Ocugen Inc   0.08 $ 4.465  Millions$ 52.903  Millions
Lenz Therapeutics Inc   0.08 $ 20.989  Millions$ 251.612  Millions
Stoke Therapeutics Inc   0.08 $ 32.080  Millions$ 401.621  Millions
Keros Therapeutics Inc   0.08 $ 42.450  Millions$ 537.566  Millions
Cytokinetics Incorporated  0.08 $ 105.815  Millions$ 1,340.052  Millions
Intellia Therapeutics Inc   0.08 $ 66.092  Millions$ 856.269  Millions
Longeveron Inc   0.08 $ 1.216  Millions$ 15.944  Millions
Tonix Pharmaceuticals Holding Corp   0.07 $ 17.556  Millions$ 243.721  Millions
Surrozen Inc   0.07 $ 7.494  Millions$ 104.044  Millions
Armata Pharmaceuticals Inc   0.07 $ 5.693  Millions$ 79.247  Millions
Biorestorative Therapies Inc   0.06 $ 0.363  Millions$ 5.720  Millions
Vir Biotechnology Inc   0.06 $ 65.495  Millions$ 1,060.098  Millions
Agape Atp Corporation  0.06 $ 1.509  Millions$ 24.653  Millions
Caribou Biosciences Inc   0.06 $ 11.203  Millions$ 185.063  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.